Your shopping cart is empty!
KemPharm Receives FDA Approval For (acetaminophen and benzhydrocodone hydrochloride) Tablets For The Treatment Of Pain
- Hits: 107
US FDA Approves New Opioid Prodrug, Apadaz, For The Treatment Of Pain
Company: KemPharm, Inc.
Generic Name: acetaminophen and benzhydrocodone hydrochloride
Previous Name: KP201
Treatment For: Pain
General information about Apadaz
The FDA has approved Apadaz (benzhydrocodone and acetaminophen) oral tablets for the short-term (no more than 14 days) management of acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
Apadaz (acetaminophen and benzhydrocodone hydrochloride) is a narcotic analgesic combination for the short-term management of acute pain.
The ingredient benzhydrocodone is a prodrug of the opioid agonist hydrocodone, meaning that while the ingredient is initially inactive, is it converted to active hydrocodone by enzymes in the intestinal tract.